The ClearBridge Large Cap Growth ESG Strategy underperformed its Russell 1000 Growth Index benchmark in the fourth quarter.

Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...

Eli Lilly and Company's correction may be coming to an end as the actual demand for its drugs seems to be holding well. Learn more about LLY stock here.

J.P. Morgan analyst Chris Schott maintained a Buy rating on Gilead Sciences (GILD – Research Report) today and set a price target of $115.00.

Truist analyst Srikripa Devarakonda says that in early questioning today, Robert Francis Kennedy Jr. reiterated that he does not want to “take ...

We recently published a list of the 12 Best Stocks to Buy in 2025 for Beginners. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best ...

Geneos Wealth Management Inc. grew its stake in First Trust SMID Cap Rising Dividend Archievers ETF (NASDAQ:SDVY – Free ...

RFG Advisory LLC purchased a new stake in Grayscale Bitcoin Trust (NYSEARCA:GBTC – Free Report) during the fourth quarter, ...